BioCentury | Dec 19, 2013
Distillery Therapeutics

Indication: Various

...information Various Obesity; neurology Diacylglycerol lipase-a (DAGLA) In vitro studies identified a selective inhibitor of DAGLA...
...treat obesity or neurodegenerative diseases. In silico modeling aided design of a tetrahydrolipstatin-based inhibitor of DAGLA...
...selective over other serine hydrolases in vitro. In cultured human neuroblastoma cells, the inhibitor decreased DAGLA...
BioCentury | Nov 29, 2012
Distillery Therapeutics

Indication: Inflammation

...genetic disruption of DAGLB models of inflammation and optimizing DAGLB, DAGLA, and dual DAGLB and DAGLA...
Items per page:
1 - 2 of 2